Zobrazeno 1 - 10
of 753
pro vyhledávání: '"Byoung Gie Kim"'
Autor:
Jaewon Na, Young Eun Chung, Il-Yeo Jang, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Chi-Son Chang, Chel Hun Choi
Publikováno v:
Obstetrics & Gynecology Science, Vol 67, Iss 2, Pp 243-252 (2024)
Objective Geriatric patients requiring gynecological surgery is increasing worldwide. However, older patients are at higher risk of postoperative morbidity and mortality, particularly cardiopulmonary complications. Laparoscopic surgery is widely used
Externí odkaz:
https://doaj.org/article/49355131f3674716b7a4fc9f4c483e4a
Autor:
Myong Cheol Lim, Youn Jin Choi, Soo-Young Hur, Yong-Man Kim, Jae Hong No, Byoung-Gie Kim, Chi Heum Cho, Sung Hoon Kim, Dae Hoon Jeong, Jae-Kwan Lee, Ji Hyun Kim, Yoon-Jeong Choi, Jung Won Woo, Young Chul Sung, Jong Sup Park
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102716- (2024)
Summary: Background: In an interim analysis of this phase 2 trial, adding the GX-188E vaccine to pembrolizumab resulted in manageable toxicity with antitumor activities in patients with recurrent or advanced cervical cancer. Here, we report the final
Externí odkaz:
https://doaj.org/article/0d6924acf16b467888aa500b44541371
Autor:
Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Eun-Suk Kang, Duck Cho, Yong-Man Kim, Kidong Kim, Jae-Weon Kim, Hee Seung Kim, Young-Tae Kim, Jung-Yun Lee, Myong Cheol Lim, Taegwon Oh, Boyeong Song, Insu Jeon, Myunghwan Park, Wu Hyun Kim, Chang-Yuil Kang, Byoung-Gie Kim
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundBVAC-C, a B cell– and monocyte-based immunotherapeutic vaccine transfected with recombinant HPV E6/E7, was well tolerated in HPV–positive recurrent cervical carcinoma patients in a phase I study. This phase IIa study investigates the an
Externí odkaz:
https://doaj.org/article/25f6fbb234fe45fb87de005ce22849a5
Autor:
Yoo-Na Kim, Boram Park, Jae Weon Kim, Byoung Gie Kim, Sang Wun Kim, Hee Seung Kim, Chel Hun Choi, Myong Cheol Lim, Natalie YL Ngoi, David SP Tan, Jung-Yun Lee
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-8 (2023)
Abstract In this multicenter, open-label, single-arm, Phase II study with Simon two-stage optimum design (NCT04361370), we investigate the efficacy and safety of triplet maintenance (olaparib, pembrolizumab, bevacizumab) in patients with platinum-sen
Externí odkaz:
https://doaj.org/article/1de04bd62c64433c9bfbae88ccacfbad
Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction
Autor:
Won-Ji Kim, Bo Ram Choi, Joseph J. Noh, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Chel Hun Choi
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Gene expression profiling using RNA-sequencing (RNA-seq) and microarray technologies is widely used in cancer research to identify biomarkers for clinical endpoint prediction. We compared the performance of these two methods in predicting protein exp
Externí odkaz:
https://doaj.org/article/e53d68c4250f436882b2226cebfdeb25
Autor:
Dong-Hoon Jang, Hyun-Gyu Lee, Banghyun Lee, Sokbom Kang, Jong-Hyeok Kim, Byoung-Gie Kim, Jae-Weon Kim, Moon-Hong Kim, Xiaojun Chen, Jae Hong No, Jong-Min Lee, Jae-Hoon Kim, Hidemich Watari, Seok Mo Kim, Sung Hoon Kim, Seok Ju Seong, Dae Hoon Jeong, Yun Hwan Kim
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0305360 (2024)
ObjectivesFertility-sparing treatment (FST) might be considered an option for reproductive patients with low-risk endometrial cancer (EC). On the other hand, the matching rates between preoperative assessment and postoperative pathology in low-risk E
Externí odkaz:
https://doaj.org/article/2b00784b3db5447aaca7190e490f3612
Autor:
Soseul Sung, Youjin Hong, Byoung‐Gie Kim, Ji‐Yeob Choi, Jae Weon Kim, Sang‐Yoon Park, Jae‐Hoon Kim, Yong‐man Kim, Jong‐Min Lee, Tae Jin Kim, Sue K. Park
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8742-8753 (2023)
Abstract Introduction This study aimed to verify the association between ovarian cancer (OC) and reproductive‐ and lifestyle‐related risk factors stratified by the subtype of OC. Methods In this matched case–control study derived from the Korea
Externí odkaz:
https://doaj.org/article/b0b3b267211940808fcf9907bbf982fa
Autor:
Bong Kyung Bae, Hyunsik Bae, Won Kyung Cho, Byoung-Gie Kim, Chel Hun Choi, Tae-Joong Kim, Yoo-Young Lee, Jeong-Won Lee, Hyun-Soo Kim, Won Park
Publikováno v:
International Journal of Gynecological Pathology; Sep2024, Vol. 43 Issue 5, p447-456, 10p
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/50bb3cdb5aed4fe492bb203ee0c52eba
Autor:
Byoung-Gie Kim, Jung-Yun Lee, SungHoon Kim, Myong Cheol Lim, Hee Seung Kim, Chel Hun Choi, Jae-Weon Kim, Junsik Park, Sang Yoon Park, Jung Bok Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background This study assessed the antitumor activity and safety of durvalumab plus tremelimumab combined with neoadjuvant chemotherapy (NAC) in patients newly diagnosed with advanced ovarian cancer. Here, we report the primary endpoint of the origin
Externí odkaz:
https://doaj.org/article/b5f93ffe8836486faaa9dcc772cf7cf4